全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用：99美元
投递稿件

查看量下载量

相关文章

更多...

细胞免疫与1型糖尿病的研究进展
Research Progress of Cellular Immunity and Type 1 Diabetes Mellitus

DOI: 10.12677/HJBM.2020.102002, PP. 9-12

Keywords: 1型糖尿病，细胞免疫，淋巴细胞
Type 1 Diabetes, Cellular Immunity, Lymphocytes

Full-Text   Cite this paper   Add to My Lib

Abstract:

1型糖尿病(Type 1 diabetes mellitus, T1DM)是一种具有致病性、适应性和自身免疫性的复杂疾病，可导致β细胞的破坏和功能障碍。目前，普遍认为T细胞是大多数T1DM患者β细胞损伤的关键介质，此外，B细胞、巨噬细胞及树突状细胞等也在其发病过程中发挥着不容忽视的作用。
Type 1 diabetes mellitus (T1DM) is a complex disease that is pathogenic, adaptive, and autoim-mune, which can cause β-cell destruction and dysfunction. At present, T cells are generally con-sidered to be the key mediator of β cell damage in most T1DM patients. In addition, B cells, mac-rophages, and dendritic cells also play a role that cannot be ignored.

References

[1]  van Belle, T.L., Coppieters, K.T. and von Herrath, M.G. (2011) Type 1 Diabetes: Etiology, Immunology, and Therapeutic Strategies. Physiological Reviews, 91, 79-118.
https://doi.org/10.1152/physrev.00003.2010
[2]  L, V., et al. (2009) Mesenchymal Stem Cells: Stem Cell Therapy Perspectives for Type 1 Diabetes. Diabetes & Metabolism, 35, 85-93.
https://doi.org/10.1016/j.diabet.2008.10.003
[3]  Bi, X., et al. (2017) Omega-3 Polyunsaturated Fatty Acids Ameliorate Type 1 Diabetes and Autoimmunity. Journal of Clinical Investigation, 127, 1757-1771.
https://doi.org/10.1172/JCI87388
[4]  Li, M., Song, L.J. and Qin, X.Y. (2014) Advances in the Cellular Immunological Pathogenesis of Type 1 Diabetes. Journal of Cellular and Molecular Medicine, 18, 749-758.
https://doi.org/10.1111/jcmm.12270
[5]  Atkinson, M.A., Eisenbarth, G.S. and Michels, A.W. (2014) Type 1 Diabetes. The Lancet, 383, 69-82.
https://doi.org/10.1016/S0140-6736(13)60591-7
[6]  Tian, J., et al. (2001) Lipopolysaccharide-Activated B Cells Down-Regulate Th1 Immunity and Prevent Autoimmune Diabetes in Nonobese Diabetic Mice. The Journal of Immunology, 167, 1081-1089.
https://doi.org/10.4049/jimmunol.167.2.1081
[7]  Hu, C.-y., et al. (2007) Treatment with CD20-Specific Antibody Prevents and Reverses Autoimmune Diabetes in Mice. The Journal of Clinical Investigation, 117, 3857-3867.
https://doi.org/10.1172/JCI32405
[8]  Chen, K., et al. (2019) B Lymphocytes Expressing High Levels of PD-L1 Are Key Regulators of Diabetes Development in Non-Obese Diabetic Mice. Molecular Immunology, 114, 289-298.
https://doi.org/10.1016/j.molimm.2019.07.026
[9]  Wang, F., et al. (2019) Loss of Ubiquitin-Conjugating Enzyme E2 (Ubc9) in Macrophages Exacerbates Multiple Low-Dose Streptozotocin-Induced Diabetes by Attenuating M2 Macrophage Polarization. Cell Death & Disease, 10, 892.
https://doi.org/10.1038/s41419-019-2130-z
[10]  HW, C., et al. (2007) The Cross-Regulatory Relationship between Human Dendritic and Regulatory T Cells and Its Role in Type 1 Diabetes Mellitus. The Review of Diabetic Studies, 4, 68-76.
https://doi.org/10.1900/RDS.2007.4.68
[11]  曹维, 刘煜. 树突状细胞与1型糖尿病的关系[J]. 国际内分泌代谢杂志, 2010, 30(1): 57-60.
[12]  Zirnheld, A.L., et al. (2019) β-Catenin Stabilization in NOD Dendritic Cells Increases IL-12 Production and Subsequent Induction of IFN-γ-Producing T Cells. Journal of Leukocyte Biology, 106, 1349-1358.
https://doi.org/10.1002/JLB.3A0919-244R

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133